Brief: Promis Neurosciences Achieves Milestone In Development Of Therapeutic Alpha-Synuclein Vaccine

ProMIS Neurosciences

22/01/2024 12:30

Jan 22 (Reuters) - ProMIS Neurosciences Inc  PMN.O :
    * PROMIS NEUROSCIENCES ACHIEVES MILESTONE IN DEVELOPMENT OF
THERAPEUTIC ALPHA-SYNUCLEIN VACCINE

Source text for Eikon:  ID:nGNX4SZpXx 
Further company coverage:  PMN.O 

 ((Reuters.Briefs@thomsonreuters.com;))